Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
NHS England’s plan to eliminate Hepatitis C decisively backed by High Court

NHS England’s plan to eliminate Hepatitis C in England by 2025 is on track after all aspects of a High Court challenge by pharmaceutical company AbbVie were dismissed. The NHS’s single largest medicines procurement, a deal worth almost £1 billion over five years, was launched in April last year but contract start dates had to be delayed by six months after legal action by AbbVie.

Published
18 January 2019
From
NHS England
Hepatitis C Prevalent in Less Than 1% of US Population

Epidemiologists found a 0.93% overall prevalence of hepatitis C virus (HCV) infection cases in the US while using a novel assessment method in a new study. The report, which included undiagnosed cases among its prevalence rates, found that approximately half of the cases occurred in just 9 states, including 5 in Appalachia.

Published
18 January 2019
From
MD Magazine
Undiagnosed HBV, HCV, HIV prevalent in newly diagnosed cancer cases

Researchers discovered a substantial proportion of patients with newly diagnosed cancer and concurrent hepatitis C or hepatitis B were unaware of their viral infection and many had no identifiable risk factors, according to a recently published study.

Published
18 January 2019
From
Healio
Egypt proposes plan to treat African Hepatitis C patients

Minister of Health Hala Zayed unveiled an Egyptian initiative to treat African people from Hepatitis C, starting with the Nile Basin countries who have an estimated 3.7 million hepatitis C patients, representing 30 percent of the total number of infected people in Africa.

Published
16 January 2019
From
Egypttoday
Temporary Decline in CD4 T-Cell Count After Hepatitis C Infection in PLWHIV

When hepatitis C (HCV) is acquired in patients with HIV infection, CD4 T-cell counts temporarily decline after HCV seroconversion, regardless of the duration of HIV or whether the patient is on combination antiretroviral therapy (cART), according to study findings published in AIDS.

Published
09 January 2019
From
Infectious Disease Advisor
Hep C Infection May Be on the Rise Among Men Using PrEP

The incidence of sexually acquired hepatitis C virus (HCV) infections appears to be rising among men who have sex with men (MSM) and use pre-exposure prophylaxis (PrEP) against HIV, U.S. researchers report.

Published
09 January 2019
From
Medscape (requires free registration)
Advanced fibrosis found in one-third of patients with HIV/HBV coinfection

Researchers observed significant fibrosis in more than one-third of patients with hepatitis B and HIV coinfection undergoing long-term combination antiretroviral therapy with viral suppression, according to a study published in American Journal of Gastroenterology.

Published
03 January 2019
From
Healio
CD4 Cells Decline After People With HIV Contract Hepatitis C

This holds true regardless of how long they’ve had HIV or whether they’re on antiretrovirals.

Published
03 January 2019
From
Poz
Pakistan has 5 million hepatitis patients

There are currently five million hepatitis patients in Pakistan and the country is listed as the most affected country after Egypt in the world.

Published
03 January 2019
From
The Nation
19 million Egyptians screened for Hepatitis C since launch of eradication campaign: Health minister

Egypt's Minister of Health Hala Zayed has announced that nearly 19 million citizens have been screened for Hepatitis C and other non-communicable diseases as part of the '100 Million Lives' campaign, the largest-ever nationwide campaign to eradicate hepatitis C launched last October.

Published
18 December 2018
From
Ahram Online
← First12345...152Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.